SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-02-024374
Filing Date
2002-06-14
Accepted
2002-06-14 17:21:03
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a2082342zsc13da.htm SC 13D/A 54972
3 EXHIBIT 99.A a2082342zex-99_a.htm EX-99.A 6572
4 EXHIBIT 99.B a2082342zex-99_b.htm EX-99.B 18559
  Complete submission text file 0000912057-02-024374.txt   82577
Mailing Address 128 SPRING STREET LEXINGTON MA 02173
Business Address 1199 MADIA STREET PASADENA CA 91103 6267921235
AUTOIMMUNE INC (Subject) CIK: 0000879106 (see all company filings)

IRS No.: 133489062 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43644 | Film No.: 02679962
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice